Skip to main content
Library homepage
 

Text Color

Text Size

 

Margin Size

 

Font Type

Enable Dyslexic Font
Biology LibreTexts

Search

  • Filter Results
  • Location
  • Classification
    • Article type
    • Author
    • Embed NoteBene
    • Cover Page
    • License
    • Show TOC
    • Transcluded
    • Annotation System
    • Number of Print Columns
    • PrintOptions
    • Print CSS
    • OER program or Publisher
    • Autonumber Section Headings
    • License Version
  • Include attachments
Searching in
About 2 results
  • 8.6: Genetics and Targeted Cancer Treatment – The Story of Gleevec™ (Imatinib)
    https://bio.libretexts.org/Courses/Clinton_College/BIO_300%3A_Introduction_to_Genetics_(Neely)/08%3A_Cancer_Genetics/8.06%3A__Genetics_and_Targeted_Cancer_Treatment__The_Story_of_Gleevec_(Imatinib)
    Thus the BCR-ABL tyrosine kinase enzyme exists only in cancer cells (and not in healthy cells) and a drug that inhibits this activity could be used to target and prevent the uncontrolled growth of the...Thus the BCR-ABL tyrosine kinase enzyme exists only in cancer cells (and not in healthy cells) and a drug that inhibits this activity could be used to target and prevent the uncontrolled growth of the cancerous CML cells.
  • 8.6: Genetics and Targeted Cancer Treatment – The Story of Gleevec™ (Imatinib)
    https://bio.libretexts.org/Courses/University_of_Arkansas_Little_Rock/Genetics_BIOL3300_(Leacock)/Genetics_Textbook/08%3A_Cancer_Genetics/8.06%3A__Genetics_and_Targeted_Cancer_Treatment__The_Story_of_Gleevec_(Imatinib)
    Thus the BCR-ABL tyrosine kinase enzyme exists only in cancer cells (and not in healthy cells) and a drug that inhibits this activity could be used to target and prevent the uncontrolled growth of the...Thus the BCR-ABL tyrosine kinase enzyme exists only in cancer cells (and not in healthy cells) and a drug that inhibits this activity could be used to target and prevent the uncontrolled growth of the cancerous CML cells.

Support Center

How can we help?